Clinical Trial Update: Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing activated T-lymphocyte cell therapy for advanced pancreatic cancer completed with posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Activated T-lymphocyte cell therapy

Snippet

Sponsor: GC Cell Corporation | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-09-16